Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases

Clinical and Experimental Immunology · Published 2025-01-01 · DOI 10.1093/cei/uxaf009

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/cei/uxaf009

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A · Clinical and Experimental Immunology · 2026 · Same journal
• Docosahexaenoic acid mitigates experimental autoimmune prostatitis by inhibiting Th17 cell differentiation via the PPARγ/NF-κB/IL-17A pathway · Clinical and Experimental Immunology · 2025 · Same journal
• BAFF-R Expression as a Potential Biomarker Associated with COVID-19 Vaccine Non-Responsiveness in Antibody-Deficient Patients · Clinical and Experimental Immunology · 2025 · Same journal
• PSMB8 stratifies therapy response in eosinophilic esophagitis · Clinical and Experimental Immunology · 2026 · Same journal
• Vitamin A deficiency enhances susceptibility to experimental autoimmune pancreatitis through activation of CD4+ T cells expressing CXCR3 and secreting CCL25 · Clinical and Experimental Immunology · 2025 · Same journal
• Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency · Clinical and Experimental Immunology · 2026 · Same journal
• The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models · Clinical and Experimental Immunology · 2025 · Same journal
• PD-1 engagement and circulating Th17 effector activity during secukinumab treatment in plaque psoriasis · Clinical and Experimental Immunology · 2026 · Same journal
• Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients · Clinical and Experimental Immunology · 2026 · Same journal
• Hereditary Angioedema: On-demand Treatment and Long-term Prophylaxis – A Global Reality · Clinical and Experimental Immunology · 2026 · Same journal